Novo Nordisk today presented new data from the OASIS 4 phase 3 trial that explored a variety of patients and hypotheses, ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Viccy Gibson paid just £70 for a month's supply of what she was told was semaglutide - the same ingredient used in ...

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

Over 24% of Indian adults across all states are now considered overweight or obese with more than 12.5 million children under ...

By now, your news feed, your dinner table conversations, and your doctor’s office have been flooded with chatter about the ...

Kidney and cardiovascular outcomes were similar between liraglutide, dulaglutide, and semaglutide among patients with type 2 diabetes.

Semaglutide, the diabetes drug at the center of a global boom in weight-loss treatments, has entered the Moroccan market through a partnership between Danish pharmaceutical company Novo Nordisk and ...